Peterson Wealth Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Peterson Wealth Services’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1	Closed	-$526	–	231
2025 Q2	$526	Buy	+1	New	+$558	﹤0.01%	217

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Peterson Wealth Services's REGN Position: Q3 2025 in Review

Peterson Wealth Services sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 1 share — an estimated $526 sold.

Peterson Wealth Services first reported a position in REGN in Q2 2025 and held it in 1 quarter. The position peaked at $526 in Q2 2025. 1,244 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

Peterson Wealth Services reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Peterson Wealth Services sold 1 Regeneron Pharmaceuticals share in Q3 2025, an estimated $526.
Peterson Wealth Services first reported a position in Regeneron Pharmaceuticals in Q2 2025 and held it in 1 quarter.
Peterson Wealth Services's Regeneron Pharmaceuticals position peaked at $526 in Q2 2025.
1,244 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Peterson Wealth Services's 13F filing for Q3 2025, filed 4 Nov 2025.